Novocure Ltd (NVCR)

[Getitgogone]

Be Vewwy Vewwy Qwiet ...We're Hunting Wabbits!!!


Shhhhhhhhhhhhhhhhhhhhhhhhhhhhh


I like this stock because even though it is a pharma company it is soooo different and so much more like a tech company mixed with a pharma but I also can appreciate what they are doing and my ever growing confidence in the success of it given FDA approvals and actual sales vs. years of R & D and the "potential" of getting something to the market.They have already arrived with a product that seems to be selling well and only will grow from here.What's not to like?

[Getitgogone]

This is where things get tricky ....LOL! Okay lurkers ..lets get some chatter on here.....

Low of 15 high of 31...beat down to 19 after high of 31 ...on way back up..does it

A.Keep going and find a new high over 31.00?

B. FALTER and fall back

C. Stay around 25.00 until New news can push it higher ?


Thoughts from the lurkers?

I think higher ......I think undervalued in regards to super ground breaking and expanding technology........I think the market has not really caught on to what this technology is doing for cancer patients.

[PennyMoocher69]

NovoCure reports Q3 EPS ($2.09) vs ($1.45) year ago; revs 104.7% y/y to $8.953 mln (no estimates)http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#nvcr

[Yankeeipo]

This stock should increase its market cap by at least 3 to 4 times over the next year. The Optune product has been approved for primary glioblastoma and the company already has built a sales force and trained numerous oncologists in the world's major cancer centers. The approval 10 days ago means these doctors must use it with the chemo or risk being sued. The results from its trials were stunning! The procedure is covered by all private insurers and shortly by cms. The company nets $14,000 per month per patient and the average patient will be on it for 2 yrs. assume that Half the patients get the treatment annually in 3 yrs that means at least 12000 patients will be using it in the us alone $168 million per month or over $ 2 billion just for the U.S. alone double it since it is approved in Europe and Japan. By the way it is also approved for non small cell lung cancer in Europe. With the great results the procedure shows with no side effects it will grow rapidly. They have great patent position, no need to share marketing and as a result Hugh profitability for many years which means a monster p/e multiple. The company is also totally unknown. Next Monday's conference is it coming out party. Stock is going much much higher.

[KIRBY]

sold half my NVCR . going to let the rest ride !

[KIRBY]

NVCR just hit $28 !!

[tombrady12nh]

Unreal!!

[KIRBY]

NVCR 26.45 its getting there !

[Roy London]

lets see 30

[KIRBY]

NVCR 23.23 now !:)

[KIRBY]

good point ....my guess pretty low until they release the secondary commons.


NVCR

[Roy London]

wonder what the float is

[KIRBY]

agree easy $30



NVCR

[Roy London]

NVCR has 30.00 written all over it...if TRIL went to 30 with no rev...and this has FDA approved drugs already and and a very nice cancer hopeful...it could see 40 bucks some day!

[KIRBY]

agree going to be a good one .g/l .



NVCR

[tombrady12nh]

This stock is going to soar IMO no pun intended lol Wish I bought at $14

[KIRBY]

NVCR $19.88 and climbing .

[KIRBY]

http://www.cnbc.com/2015/10/07/cramer-know-your-ipo-good-bad-ugly-biotechs.html


NVCR

[KIRBY]

http://www.novocure.com/~/media/Files/N/Novocure/press-release/2015/07-oct-2015.pdf

[KIRBY]

printing $21 ah .



NVCR

[KIRBY]

added some NVCR at 19.65 a Cramer pick . long term hold